438 related articles for article (PubMed ID: 37444616)
1. Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.
Hosea R; Hillary S; Wu S; Kasim V
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444616
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic role of Yin Yang 1.
Zhang Q; Stovall DB; Inoue K; Sui G
Crit Rev Oncog; 2011; 16(3-4):163-97. PubMed ID: 22248053
[TBL] [Abstract][Full Text] [Related]
3. The role of transcription factor Yin Yang-1 in colorectal cancer.
Shao Z; Yang W; Meng X; Li M; Hou P; Li Z; Chu S; Zheng J; Bai J
Cancer Med; 2023 May; 12(10):11177-11190. PubMed ID: 36880159
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.
Atchison M; Basu A; Zaprazna K; Papasani M
Crit Rev Oncog; 2011; 16(3-4):143-61. PubMed ID: 22248052
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
Baritaki S; Huerta-Yepez S; Sakai T; Spandidos DA; Bonavida B
Mol Cancer Ther; 2007 Apr; 6(4):1387-99. PubMed ID: 17431117
[TBL] [Abstract][Full Text] [Related]
6. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.
Wottrich S; Kaufhold S; Chrysos E; Zoras O; Baritaki S; Bonavida B
Drug Resist Updat; 2017 Jan; 30():28-38. PubMed ID: 28363333
[TBL] [Abstract][Full Text] [Related]
7. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
[TBL] [Abstract][Full Text] [Related]
8. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: a therapeutic target.
Bonavida B; Kaufhold S
Pharmacol Ther; 2015 Jun; 150():149-68. PubMed ID: 25619146
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.
Gordon S; Akopyan G; Garban H; Bonavida B
Oncogene; 2006 Feb; 25(8):1125-42. PubMed ID: 16314846
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells.
Baritaki S; Suzuki E; Umezawa K; Spandidos DA; Berenson J; Daniels TR; Penichet ML; Jazirehi AR; Palladino M; Bonavida B
J Immunol; 2008 May; 180(9):6199-210. PubMed ID: 18424742
[TBL] [Abstract][Full Text] [Related]
12. Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer.
Vivarelli S; Falzone L; Grillo CM; Bonavida B; Crimi C; La Mantia I; Libra M
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205667
[TBL] [Abstract][Full Text] [Related]
13. The Yin and Yang of YY1 in tumor growth and suppression.
Khachigian LM
Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
[TBL] [Abstract][Full Text] [Related]
14. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review.
Chen Q; Wang WJ; Jia YX; Yuan H; Wu PF; Ge WL; Meng LD; Huang XM; Shen P; Yang TY; Miao Y; Zhang JJ; Jiang KR
Cell Biosci; 2021 May; 11(1):86. PubMed ID: 33985581
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
[TBL] [Abstract][Full Text] [Related]
16. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic YY1 Inhibitors in Cancer: ALL in ONE.
Bonavida B
Crit Rev Oncog; 2017; 22(1-2):37-47. PubMed ID: 29604935
[TBL] [Abstract][Full Text] [Related]
18. Nitric Oxide-Mediated Enhancement and Reversal of Resistance of Anticancer Therapies.
Hays E; Bonavida B
Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31533363
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.
Zhao L; Li R; Gan YH
Cell Death Dis; 2018 Jul; 9(7):747. PubMed ID: 29970878
[TBL] [Abstract][Full Text] [Related]
20. The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1.
Verheul TCJ; van Hijfte L; Perenthaler E; Barakat TS
Front Cell Dev Biol; 2020; 8():592164. PubMed ID: 33102493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
